UPDATE: Evercore ISI Downgrades Cepheid (CPHD) to Sell; Analyst Sees Risk of Multiple Compression
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Wedbush Cuts Price Target to $66 on Cepheid (CPHD) Following 2Q15
July 24, 2015 10:13 AM EDTWedbush reiterated an Outperform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $66.00 (from $67.00), following 2Q15 results. CPHD reported 2Q15 sales of $133 MM compared to $131 MM estimates. Reported GAAP EPS was ($0.23), compared with consensus EPS loss of ($0.21).
Analyst Zarak Khurshid commented,... More
Needham & Company Raises Price Target to $70 on Cepheid (CPHD) Following 2Q15
July 24, 2015 7:34 AM EDTNeedham & Company reiterated a Buy rating on Cepheid (NASDAQ: CPHD), and raised the price target to $70.00 (from $66.00), following 2Q15 results. Revenue was $132.5M vs. consensus of $130.5M. Non-GAAP EPS was reported at ($0.23) vs. consensus of ($0.21).
Analyst Mike Matson commented, "CPHD's 2Q15 revenue beat... More
Cepheid (CPHD) PT Raised to $72 at MKM Partners
July 24, 2015 7:22 AM EDTMKM Partners analyst Peter Lawson reiterated a Buy rating and boosted his price target on Cepheid (NASDAQ: CPHD) to $72.00 (from $65.00) following Q2 results.
Lawson commented, "We are reiterating our Buy rating and raising our PT to $72 following 2Q results. CPHD beat... More
Cepheid (CPHD) Tops Q2 EPS by 15c
July 23, 2015 4:41 PM EDTCepheid (NASDAQ: CPHD) reported Q2 EPS of ($0.06), $0.15 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $132.5 million versus the consensus estimate of $130.7 million.
For earnings history and earnings-related data on Cepheid (CPHD) click here.
... More